CELLENS IS ON SOSV HUMAN HEALTH 100 LIST
Welcome to the second annual SOSV Human Health 100. The list captures SOSV’s 100 most exciting companies in human health as of April 2023. SOSV’s core mission, which we pursue through our IndieBio, HAX, and Orbit startup development programs, is to fund and foster startups that will improve human and planetary health. In addition to the Human Health 100, […]
CELLENS WON GOLDEN TICKET IGNITE AWARD
CAMBRIDGE, Mass., Oct. 5, 2022 /PRNewswire/ — LabCentral Ignite, with support from key sponsors Pfizer, Bristol Myers Squibb and Mission BioCapital, today announced the winners of its second annual Golden Ticket contest: Cellens, Guardian Bio, QurCan Therapeutics and Spheric Bio. The winners were unveiled at LabCentral Ignite’s bioDiversity Summit & Awards, a new annual event that brings the entire biotech ecosystem together to discuss […]
